Get the Stockscreener App
0.6482
8.80%
-0.0503
Agilon Health Inc stock is traded at $0.6482, with a volume of 5.25M.
It is down -8.80% in the last 24 hours and up +0.87% over the past month.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
See More
Previous Close:
$0.6985
Open:
$0.7
24h Volume:
5.25M
Relative Volume:
0.72
Market Cap:
$268.92M
Revenue:
$4.78B
Net Income/Loss:
$-284.68M
P/E Ratio:
-0.9394
EPS:
-0.69
Net Cash Flow:
$-184.84M
1W Performance:
+7.13%
1M Performance:
+0.87%
6M Performance:
-46.92%
1Y Performance:
-82.01%
1-Day Range:
$0.625
$0.727
1-Week Range:
$0.53
$0.727
52-Week Range:
$0.3375
$5.77
Agilon Health Inc Stock (AGL) Company Profile
Name
Agilon Health Inc
Sector
Industry
Phone
562-256-3800
Address
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
0.6482 | 289.79M | 4.78B | -284.68M | -184.84M | -0.69 |
|
HCA
Hca Healthcare Inc
|
534.03 | 121.74B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
239.72 | 21.29B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.02 | 12.86B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
207.43 | 12.32B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
196.26 | 12.36B | 16.08B | 1.20B | 1.06B | 17.82 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Aug-06-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-25 | Upgrade | Citigroup | Neutral → Buy |
| Apr-08-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-10-25 | Upgrade | Citigroup | Sell → Neutral |
| Jan-10-25 | Initiated | Needham | Hold |
| Dec-16-24 | Initiated | Macquarie | Neutral |
| Dec-11-24 | Initiated | Bernstein | Mkt Perform |
| Nov-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-30-24 | Downgrade | Citigroup | Neutral → Sell |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Apr-22-24 | Initiated | Citigroup | Neutral |
| Mar-06-24 | Initiated | Barclays | Underweight |
| Feb-26-24 | Downgrade | Jefferies | Buy → Hold |
| Feb-26-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Stifel | Buy → Hold |
| Jan-08-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-05-24 | Downgrade | Truist | Buy → Hold |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-21-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-23 | Initiated | The Benchmark Company | Buy |
| Jun-13-23 | Initiated | Evercore ISI | In-line |
| Dec-09-22 | Initiated | Stifel | Buy |
| Sep-14-22 | Initiated | RBC Capital Mkts | Outperform |
| Sep-12-22 | Initiated | Goldman | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| Jun-24-22 | Initiated | BTIG Research | Neutral |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Oct-20-21 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| May-11-21 | Initiated | William Blair | Outperform |
| May-10-21 | Initiated | BofA Securities | Buy |
| May-10-21 | Initiated | Deutsche Bank | Buy |
| May-10-21 | Initiated | Goldman | Buy |
| May-10-21 | Initiated | JP Morgan | Overweight |
| May-10-21 | Initiated | Truist | Buy |
| May-10-21 | Initiated | Wells Fargo | Overweight |
| May-10-21 | Initiated | Wolfe Research | Outperform |
View All
Agilon Health Inc Stock (AGL) Latest News
Kuehn Law Encourages Investors of Agilon Health, Inc. to Contact Law Firm - PR Newswire
Agilon Health Charts Risky Turnaround After Steep Losses - TipRanks
agilon health (AGL) Shares Skyrocket, What You Need To Know - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
agilon health (AGL) markets chief buys 500,000 shares in open market - Stock Titan
Agilon Health (NYSE:AGL) Slips on Target Cut in NYSE Composite - Kalkine Media
Agilon Health (NYSE:AGL) Price Target Cut to $0.75 by Analysts at Citigroup - MarketBeat
agilon health, inc. (AGL) Investor Outlook: Assessing a 54.75% Potential Upside Amidst Challenging Metrics - DirectorsTalk Interviews
Rosen Law Firm Encourages agilon health Investors to Secure Counsel Before March 2 Deadline - National Today
AGL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit – AGL - GlobeNewswire Inc.
AGL FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026 - bastillepost.com
agilon health at TD Cowen Conference: Strategic Moves for 2026 By Investing.com - Investing.com Canada
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of agilon health, inc. Investors - GlobeNewswire
Shareholders of agilon health, inc. Should Contact Levi & Korsinsky Before March 2, 2026 to Discuss Your RightsAGL - PR Newswire
Agilon health, inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsAGL - marketscreener.com
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
AGILON CLASS ACTION DEADLINE MARCH 2nd: Bragar Eagel & - GlobeNewswire
AGL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026 - PR Newswire
02:52 ETAGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm - Longbridge
agilon health (AGL) Q4 2025 Earnings Transcript - AOL.com
agilon health, inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:AGL) 2026-02-27 - Seeking Alpha
AGL Stock: Wells Fargo Raises Price Target, Maintains Overweight - GuruFocus
Why agilon health (AGL) Stock Is Trading Lower Today - Finviz
Wells Fargo & Company Raises Agilon Health (NYSE:AGL) Price Target to $1.50 - MarketBeat
Barclays Has Lowered Expectations for Agilon Health (NYSE:AGL) Stock Price - MarketBeat
Agilon Health Reports 2025 Losses, Outlines 2026 Turnaround - The Globe and Mail
Agilon Health Q4 2025 Results: Loss Widens, Revenue Beats ForecastsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
The Gross Law Firm Notifies Shareholders of agilon health, - GlobeNewswire
Why Is agilon health (AGL) Stock Soaring Today - Finviz
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming DeadlinesAGL - PR Newswire
Deadline Alert: agilon health, inc. (AGL) Shareholders Who - GlobeNewswire
AGL INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Agilon Health Investors of the Securities Class Action Lawsuit Deadline on March 2, 2026 - ChartMill
Compared to Estimates, Agilon (AGL) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
AGILON HEALTH, INC. (NYSE: AGL) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Agilon Health, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Agilon Health Q4 Earnings Call Highlights - MarketBeat
Agilon Health Q4 Loss Of US$0.46 Per Share Reinforces Bearish Profitability Concerns - Sahm
Agilon Health Q4 2025 Earnings Call Transcript - MarketBeat
Agilon Health (NYSE:AGL) Announces Quarterly Earnings Results, Misses Expectations By $0.19 EPS - MarketBeat
agilon health Q4 2025 slides: path to breakeven after $296M loss - Investing.com
agilon health Q4 2025 slides: path to breakeven after $296M loss By Investing.com - Investing.com South Africa
Agilon Health Deadline: AGL Investors Have Opportunity to Lead a - GuruFocus
Earnings call transcript: Agilon Health Q4 2025 misses EPS, sees revenue growth - Investing.com
agilon health inc reports results for the quarter ended September 30Earnings Summary - TradingView
AGILON HEALTH ($AGL) Releases Q4 2025 Earnings - Quiver Quantitative
Agilon Health Q4 Earnings Beat Expectations Despite EPS Miss - Intellectia AI
Agilon: Q4 Earnings Snapshot - marketscreener.com
Agilon health : Fourth Quarter 2025 Earnings Presentation - marketscreener.com
Agilon Health Q4 revenue beats estimates - TradingView
Agilon Health Inc Stock (AGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):